| Literature DB >> 32283898 |
Ramazan Akçan1, Halit Canberk Aydogan1, Mahmut Şerif Yildirim2, Burak Taştekin1, Necdet Sağlam3.
Abstract
Background/aim: Due to nanomaterials’ potential benefits for diagnosis and treatment, they are widely used in medical applications and personal care products. Interaction of nanomaterials, which are very small in size, with tissue, cell and microenvironment, can reveal harmful effects that cannot be created with chemically identical and larger counterparts in biological organisms. In this review, a challenge for future medicine, nanotoxicity of nanomaterials is discussed. Materials and methods: A detailed review of related literature was performed and evaluated as per medical applications of nanomaterials their toxicity. Results and conclusion: Most authors state “the only valid technology will be nanotechnology in the next era”; however, there is no consensus on the impact of this technology on humankind, environment and ecological balance. Studies dealing with the toxic effect of nanomaterials on human health have also varied with developing technology. Nanotoxicology studies such as in vivo-like on 3D human organs, cells, advanced genetic studies, and -omic approaches begin to replace conventional methods. Nanotoxicity and adverse effects of nanomaterials in exposed producers, industry workers, and patients make nanomaterials a double-edged sword for future medicine. In order to control and tackle related risks, regulation and legislations should be implemented, and researchers have to conduct joint multidisciplinary studies in various fields of medical sciences, nanotechnology, nanomedicine, and biomedical engineering. This work is licensed under a Creative Commons Attribution 4.0 International License.Entities:
Keywords: Nanotechnology; nanotoxicity; bio-nanomaterials; future medicine
Year: 2020 PMID: 32283898 PMCID: PMC7379444 DOI: 10.3906/sag-1912-209
Source DB: PubMed Journal: Turk J Med Sci ISSN: 1300-0144 Impact factor: 0.973
A summary of literature related toxicity tests of nanomaterials [131-147].
| Toxicity test | Purpose | Nanomaterials |
|---|---|---|
| Transmission electron microscopy | Determination of intracellular localization | TiO2, silver,fullerene [131–133] |
| Light microscopy | Physicochemical properties | Singled walled carbon nanotubes, silver [132,134] |
| Hemoglobin estimation | Hemolysis | SiO2 [135] |
| Micronucleus test | Genotoxicity | Different types of nanoparticles [136] |
| Commet assay test | DNA damage | Metal, metal oxide nanoparticles [137] |
| Lactate dehydrogenase | Cell viability | Carbon nanoparticles [138,139] |
| Tetrazolium salts | Carbon nanoparticles, fullerenes [140,141] | |
| Alamar Blue | Quantum dots [142] | |
| Propidium iodide | Carbon nanoparticles [143,144] | |
| Neutral red assay test | Carbon nanotubes [140,145] | |
| Caspase-3 activity | Apoptosis | Silver nanoparticles [132] |
| Acridine orange/ethidium bromide | Silver nanoparticles [146] | |
| ROS production | Oxidative stress | TiO2 [131] |
| Levels of glutathione peroxidase, catalase, superoxide dismutase | Polymeric nanoparticles [147] | |
| Lipid peroxidation, vitamin E | Singled walled carbon nanotubes [105] |